RhD+ Blood Transfusion to Asian-type DEL Recipients

Clinical trial NCT03727230 · COMPLETED

Trial details

NCT number: NCT03727230
Sponsor: Guangzhou Blood Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Blood Transfusion Rhesus Isoimmunisation Due to Anti-D Blood Group Antigen Abnormality

Start date: 2016-10-01
Primary completion: 2021-10-09
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.